Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Background Identifying clinical correlates associated with reduced suicidal ideation may highlight new avenues for the treatment of suicidal thoughts. Anhedonia occurs across psychiatric diagnoses and has been associated with specific neural circuits in response to rapid-acting treatments, such as ketamine. This analysis sought to evaluate whether reductions in suicidal ideation after ketamine administration were related to reduced levels of anhedonia, independent of depressive symptoms. Methods This post-hoc analysis included treatment-resistant patients with either major depressive disorder (MDD) or bipolar disorder (BD) from several clinical trials of ketamine. Anhedonia was assessed using a subscale of the Beck Depression Inventory (BDI) and the Snaith-Hamilton Pleasure Scale (SHAPS). The outcome of interest was suicidal ideation, as measured by a subscale of the Scale for Suicide Ideation (SSI5), one day post-ketamine administration. Results Anhedonia, as measured by the SHAPS, was associated with suicidal thoughts independent of depressive symptoms both before and after ketamine administration. One day post-ketamine administration, improvements on the SHAPS accounted for an additional 13% of the variance in suicidal thought reduction, beyond the influence of depressive symptoms. The BDI anhedonia subscale was not significantly associated with suicidal thoughts after adjusting for depressive symptoms. Limitations Data were limited to patients experiencing a major depressive episode and may not be generalizable to patients experiencing an active suicidal crisis. Conclusions Suicidal thoughts may be related to symptoms of anhedonia independent of other depressive symptoms. These results have implications for the potential mechanisms of action of ketamine on suicidal thoughts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The interpersonal theory of suicide.
Van Orden, K. A., Witte, T. K., Cukrowicz, K. C., Braithwaite, S. R., Selby, E. A., & Joiner, T. E. (2010) · Psychological Review · doi:10.1037/a0018697 · Cited by 5,292
Assessment of suicidal intention: The Scale for Suicide Ideation.
Beck, A. T., Kovacs, M., & Weissman, A. (1979) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.47.2.343 · Cited by 3,419
Cross-national prevalence and risk factors for suicidal ideation, plans and attempts
Nock, M. K., Borges, G., Bromet, E. J., Alonso, J., Angermeyer, M., Beautrais, A., Bruffaerts, R., Chiu, W. T., de Girolamo, G., Gluzman, S., et al. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.040113 · Cited by 2,654 · cited 2×
“Better treatment of suicidal thoughts—which have a worldwide lifetime prevalence of almost 10% (Nock et al., 2008)—is a critical target in preventing suicide deaths.”
BackgroundInfluentialLinehan, M. M., Comtois, K. A., Murray, A. M., Brown, M. Z., Gallop, R. J., Heard, H. L., Korslund, K. E., Tutek, D. A., Reynolds, S. K., & Lindenboim, N. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.7.757 · Cited by 2,025 · cited 1×
“Although psychotherapy treatments such as cognitive-behavioral therapy (CBT) (Brown et al., 2005) and dialectical behavioral therapy (Linehan et al., 2006) have been shown to reduce suicidal behavior, only one medication, clozapine, is FDA-approved for suicide risk; however, clozapine use is…”
BackgroundA scale for the assessment of hedonic tone the Snaith-Hamilton pleasure scale
Snaith, R. P., Hamilton, M., Morley, S., Humayan, A., Hargreaves, D., & Trigwell, P. (1995) · British Journal of Psychiatry · doi:10.1192/bjp.167.1.99 · Cited by 1,778
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Zanos, P., Moaddel, R., Morris, P. J., Georgiou, P., Fischell, J., Elmer, G. I., Alkondon, M., Yuan, P., Pribut, H. J., Singh, N. S., et al. (2016) · Nature · doi:10.1038/nature17998 · Cited by 1,609
Reconsidering anhedonia in depression: Lessons from translational neuroscience
Treadway, M. T., & Zald, D. H. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.06.006 · Cited by 1,579 · cited 4×
“, 2016)—may be used to treat patients with suicidal ideation by decreasing anhedonia symptoms and improving neural responses in the reward system (Treadway and Zald, 2011).”
BackgroundInfluentialWatson, D., Weber, K., Assenheimer, J. S., Clark, L. A., Strauss, M. E., & McCormick, R. A. (1995) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.104.1.3 · Cited by 1,423
Cognitive Therapy for the Prevention of Suicide Attempts: A Randomized Controlled Trial
Brown, G. K., Ten Have, T., Henriques, G. R., Xie, S. X., Hollander, J. E., & Beck, A. T. (2005) · JAMA · doi:10.1001/jama.294.5.563 · Cited by 1,045 · cited 4×
“Although psychotherapy treatments such as cognitive-behavioral therapy (CBT) (Brown et al., 2005) and dialectical behavioral therapy (Linehan et al.”
BackgroundInfluentialAnticipatory and consummatory components of the experience of pleasure: A scale development study
Gard, D. E., Gard, M. G., Kring, A. M., & John, O. P. (2006) · Journal of Research in Personality · doi:10.1016/j.jrp.2005.11.001 · Cited by 1,015 · cited 2×
“Other measures such as the Temporal Experience of Pleasure Scale (TEPS) (Gard et al., 2006), which distinguishes between consummatory and motivational anhedonia, could be useful in linking suicidal thoughts to specific aspects of anhedonia.”
BackgroundDiazgranados, N., Ibrahim, L., Brutsche, N. E., Newberg, A., Kronstein, P., Khalife, S., Kammerer, W. A., Quezado, Z., Luckenbaugh, D. A., Salvadore, G., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.90 · Cited by 963 · cited 1×
“Clinical intravenous administration of sub-anesthetic doses of ketamine has been associated with rapid (within hours) reductions in suicidal thoughts across several investigations (Diazgranados et al., 2010; Larkin and Beautrais, 2011; Murrough et al., 2015; Price et al., 2009; Zarate et al., 2012).”
BackgroundSelf-citationZarate, C. A., Brutsche, N. E., Ibrahim, L., Franco-Chaves, J., Diazgranados, N., Cravchik, A., Selter, J., Marquardt, C. A., Liberty, V., & Luckenbaugh, D. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.12.010 · Cited by 811 · cited 2×
“…from three independent clinical trials of ketamine (all substudies of NCT00088699), including two placebo-controlled trials of ketamine and one open-label trial in which participants were randomized to receive add-on riluzole after ketamine infusion (Ibrahim et al., 2012; Zarate et al., 2012).”
BackgroundSelf-citationMeasuring the Suicidal Mind: Implicit Cognition Predicts Suicidal Behavior
Nock, M. K., Park, J. M., Finn, C. T., Deliberto, T. L., Dour, H. J., & Banaji, M. R. (2010) · Psychological Science · doi:10.1177/0956797610364762 · Cited by 624 · cited 1×
“These include implicit suicide risk (Nock et al., 2010) as well as the dot-probe task; indeed, a recent metaanalysis of studies using the dot-probe task concluded that depressed patients have an attentional bias away from positive information (Winer and Salem, 2016).”
BackgroundPrice, R. B., Nock, M. K., Charney, D. S., & Mathew, S. J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.04.029 · Cited by 600 · cited 1×
“Clinical intravenous administration of sub-anesthetic doses of ketamine has been associated with rapid (within hours) reductions in suicidal thoughts across several investigations (Diazgranados et al., 2010; Larkin and Beautrais, 2011; Murrough et al., 2015; Price et al., 2009; Zarate et al., 2012).”
BackgroundAssessing anhedonia in depression: potentials and pitfalls
Rizvi, S. J., Pizzagalli, D. A., Sproule, B. A., & Kennedy, S. H. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.004 · Cited by 571 · cited 2×
“The SHAPS may also be a particularly helpful tool for understanding the relationship between suicidal thoughts and anhedonia, given that it is unaffected by demographics and has established internal consistency and validation in MDD clinical trials (Rizvi et al., 2016).”
BackgroundSuicidal Thoughts and Behaviors Among Adults Aged ≥18 Years — United States, 2015–2019
Ivey-Stephenson, A. Z., Crosby, A. E., Hoenig, J. M., Gyawali, S., Park-Lee, E., & Hedden, S. L. (2022) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss7101a1 · Cited by 512
Craske, M. G., Meuret, A. E., Ritz, T., Treanor, M., & Dour, H. J. (2016) · Depression and Anxiety · doi:10.1002/da.22490 · Cited by 387 · cited 3×
“Perhaps more importantly, the results underscore the possibility that therapies already available for anhedonia—such as CBT and BAT (Craske et al., 2016)—may be used to treat patients with suicidal ideation by decreasing anhedonia symptoms and improving neural responses in the reward system…”
BackgroundIbrahim, L., DiazGranados, N., Franco-Chaves, J., Brutsche, N., Henter, I. D., Kronstein, P., Moaddel, R., Wainer, I., Luckenbaugh, D. A., Manji, H. K., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.338 · Cited by 309 · cited 2×
“Data were drawn from three independent clinical trials of ketamine (all substudies of NCT00088699), including two placebo-controlled trials of ketamine and one open-label trial in which participants were randomized to receive add-on riluzole after ketamine infusion (Ibrahim et al., 2012; Zarate et al., 2012).”
BackgroundMethodSelf-citationKetamine for rapid reduction of suicidal ideation: a randomized controlled trial
Murrough, J. W., Soleimani, L., DeWilde, K. E., Collins, K. A., Lapidus, K. A., Iacoviello, B. M., Lener, M., Kautz, M., Kim, J., Stern, J. B., et al. (2015) · Psychological Medicine · doi:10.1017/s0033291715001506 · Cited by 297 · cited 1×
“Clinical intravenous administration of sub-anesthetic doses of ketamine has been associated with rapid (within hours) reductions in suicidal thoughts across several investigations (Diazgranados et al., 2010; Larkin and Beautrais, 2011; Murrough et al., 2015; Price et al., 2009; Zarate et al., 2012).”
BackgroundRelationships among suicide ideators, attempters, and multiple attempters in a young-adult sample.
Rudd, M. D., Joiner, T., & Rajab, M. H. (1996) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.105.4.541 · Cited by 290
Ballard, E. D., Ionescu, D. F., Vande Voort, J. L., Niciu, M. J., Richards, E. M., Luckenbaugh, D. A., Brutsché, N. E., Ameli, R., Furey, M. L., & Zarate, C. A. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.07.027 · Cited by 286
Self-citationThe effects of psychotherapy on neural responses to rewards in major depression
Dichter, G. S., Felder, J. N., Petty, C., Bizzell, J., Ernst, M., & Smoski, M. J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.06.021 · Cited by 278 · cited 2×
“Importantly, psychotherapeutic techniques such as Behavioral Activation Therapy (BAT) have been associated with changes in reward processing (Dichter et al., 2009), which may also provide additional potential treatment options”
BackgroundMethodLally, N., Nugent, A. C., Luckenbaugh, D. A., Ameli, R., Roiser, J. P., & Zarate, C. A. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.105 · Cited by 271
Self-citationTrends in US emergency department visits for attempted suicide and self-inflicted injury, 1993-2008.
Ting, S. A., Sullivan, A. F., Boudreaux, E. D., Miller, I., & Camargo, C. A. (2012) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2012.03.020 · Cited by 252
KUO, W.-H., GALLO, J. J., & TIEN, A. Y. (2001) · Psychological Medicine · doi:10.1017/s0033291701004482 · Cited by 237
Neural correlates of change in major depressive disorder anhedonia following open-label ketamine
Lally, N., Nugent, A. C., Luckenbaugh, D. A., Niciu, M. J., Roiser, J. P., & Zarate, C. A. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114568041 · Cited by 224
Self-citationDillon, D. G., Rosso, I. M., Pechtel, P., Killgore, W. D. S., Rauch, S. L., & Pizzagalli, D. A. (2014) · Depression and Anxiety · doi:10.1002/da.22202 · Cited by 209 · cited 1×
“Finally, it is possible that tasks of reward responsiveness (Dillon et al., 2014) could be used to more directly connect these symptoms to specific neural circuits.”
BackgroundAssessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant
Ballard, E. D., Luckenbaugh, D. A., Richards, E. M., Walls, T. L., Brutsché, N. E., Ameli, R., Niciu, M. J., Vande Voort, J. L., & Zarate, C. A. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.06.003 · Cited by 80 · cited 4×
“total SSI in clinical trials of treatments such as ketamine may be able to capture rapid changes in symptoms over minutes to hours (Ballard et al., 2015).”
BackgroundMethodInfluentialSelf-citation
Cited by
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Zanos, P., Moaddel, R., Morris, P. J., Riggs, L. M., Highland, J. N., Georgiou, P., Pereira, E. F. R., Albuquerque, E. X., Thomas, C. J., Zarate, C. A., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.015198 · Cited by 1,260
“, 2014) and decreases anhedonia (Lally et al., 2014, 2015; Ballard et al., 2017) in patients suffering frommajor depression.”
BackgroundSelf-citationMechanisms of ketamine action as an antidepressant
Zanos, P., & Gould, T. D. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.255 · Cited by 1,127
McIntyre, R. S., Rosenblat, J. D., Nemeroff, C. B., Sanacora, G., Murrough, J. W., Berk, M., Brietzke, E., Dodd, S., Gorwood, P., Ho, R., et al. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20081251 · Cited by 731
Self-citationAnhedonia is associated with suicidal ideation independently of depression: A meta-analysis
Ducasse, D., Loas, G., Dassa, D., Gramaglia, C., Zeppegno, P., Guillaume, S., Olié, E., & Courtet, P. (2018) · Depression and Anxiety · doi:10.1002/da.22709 · Cited by 269
Molecular Pharmacology and Neurobiology of Rapid-Acting Antidepressants
Gould, T. D., Zarate, C. A., & Thompson, S. M. (2019) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-052811 · Cited by 133
“The reduction in thoughts of suicide associated with ketamine treatment is correlated with the antianhedonic response, independent of depression improvement (31).”
BackgroundSelf-citation
Metadata
- Authors
- Ballard, E. D., Wills, K., Lally, N., Richards, E. M., Luckenbaugh, D. A., Walls, T., Ameli, R., Niciu, M. J., Brutsche, N. E., Park, L., & Zarate, C. A.
- Venue
- Journal of Affective Disorders
- Publisher
- Elsevier BV
- Published
- 2017-08
- Volume
- 218
- Pages
- 195-200
- ISSN
- 0165-0327 (ISSN-L)
- OpenAlex
- W2608847325
- Cited by
- 146
- References
- 28
- FWCI
- 6.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.